Back to top

Compensatory Arrangements for Executive Officers

Executive Compensation Plan Agreement

Compensatory Arrangements for Executive Officers | Document Parties: OSI PHARMACEUTICALS INC You are currently viewing:
This Executive Compensation Plan Agreement involves

OSI PHARMACEUTICALS INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Compensatory Arrangements for Executive Officers
Date: 2/27/2009
Industry: Biotechnology and Drugs     Sector: Healthcare

Compensatory Arrangements for Executive Officers, Parties: osi pharmaceuticals inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.63

Compensatory Arrangements for Executive Officers

     The Compensation Committee (the “Committee”) of the Board of Directors of OSI Pharmaceuticals, Inc. (“OSI” or the “Company”) approved the 2009 salaries and 2008 cash bonuses for OSI’s named executive officers (as that term is defined in Item 402 of Regulation S-K) as set forth in OSI’s proxy statement dated May 2, 2008 (the “2008 Proxy”). The following table sets forth the annual base salary level of such named executive officers for 2009 and the 2008 cash bonuses for each such officer as well as the 2009 annual base salary of the Company’s current chief financial officer:

 

 

 

 

 

 

 

 

 

Name and Position

 

2009 Base Salary

 

 

2008 Bonus

 

Colin Goddard, Ph.D.

 

$

640,000

 

 

$

705,000

 

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael G. Atieh (1)

 

$

 

 

$

233,000

 

Former Executive Vice President, Chief Financial Officer and Treasurer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gabriel Leung

 

$

455,000

 

 

$

235,000

 

Executive Vice President and President, (OSI) Oncology

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pierre Legault (2)

 

$

450,000

 

 

$

 

Executive Vice President, Chief Financial Officer and Treasurer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anker Lundemose, M.D., Ph.D., D.Sc.

 

£

236,000

 

 

£

130,000

 

Executive Vice President and President, (OSI) Prosidion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Robert L. Simon

 

$

415,000

 

 

$

223,000

 

Executive Vice President, Pharmaceutical Development and Manufacturing

 

 

 

 

 

 

 

 

 

(1)

 

Mr. Atieh retired from his position as the Company’s Chief Financial Officer and Treasurer effective December 29, 2008 and its Executive Vice President effective January 5, 2009, and received a 2008 bonus in accordance with the terms of his employment agreement.

 

(2)

 

Mr. Legault’s employment as Executive Vice President, Chief Financial Officer and Treasurer commenced on December 29, 2008. As such, he was not entitled to a bonus for 2008.

Cash Bonuses

     The 2008 bonus awards were computed in accordance with the Committee’s policy of awarding annual bonuses for executive officers, as disclosed in the Compensation Discussion and Analysis section of the 2008 Proxy. The bonus awards were paid out in February 2009 based on individual and corporate performance measurers considered in December 2008 and February 2009, respectively. OSI has established a discretionary annual cash bonus program for all of its employees, including its executive officers. The bonus targets, which are a percentage of base salary, for all of its executive officers are based upon their respective grade levels. The


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more